Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jonas E. Adolph"'
Autor:
Jonas E. Adolph, Gudrun Fleischhack, Sebastian Tschirner, Lydia Rink, Christine Dittes, Ruth Mikasch, Philipp Dammann, Martin Mynarek, Denise Obrecht-Sturm, Stefan Rutkowski, Brigitte Bison, Monika Warmuth-Metz, Torsten Pietsch, Stefan M. Pfister, Kristian W. Pajtler, Till Milde, Rolf-Dieter Kortmann, Stefan Dietzsch, Beate Timmermann, Stephan Tippelt
Publikováno v:
Cancers, Vol 16, Iss 11, p 1955 (2024)
Background: Radiotherapy (RT) involving craniospinal irradiation (CSI) is important in the initial treatment of medulloblastoma. At recurrence, the re-irradiation options are limited and associated with severe side-effects. Methods: For pre-irradiate
Externí odkaz:
https://doaj.org/article/d3d6022ebfb7498792ed00f29dae73d7
Autor:
Christine Gaab, Jonas E. Adolph, Stephan Tippelt, Ruth Mikasch, Denise Obrecht, Martin Mynarek, Stefan Rutkowski, Stefan M. Pfister, Till Milde, Olaf Witt, Brigitte Bison, Monika Warmuth-Metz, Rolf-Dieter Kortmann, Stefan Dietzsch, Torsten Pietsch, Beate Timmermann, Ronald Sträter, Udo Bode, Andreas Faldum, Robert Kwiecien, Gudrun Fleischhack
Publikováno v:
Cancers, Vol 14, Iss 3, p 471 (2022)
Recurrent medulloblastomas are associated with survival rates n = 30/93) found mainly in molecular subgroup 3 were associated with markedly worse median PFS (HR: 2.34) and OS (HR: 3.26) in regression analyses. A significant survival advantage was fou
Externí odkaz:
https://doaj.org/article/b84c8b687ba147c083724fcf8ceb6e49
Autor:
Jonas E Adolph, Stephan Tippelt, Sebastian Tschirner, Christine Gaab, Ruth Mikasch, Martin Mynarek, Stefan Rutkowski, Monika Warmuth-Metz, Brigitte Bison, Stefan M Pfister, Olaf Witt, Torsten Pietsch, Rolf-Dieter Kortmann, Stefan Dietzsch, Beate Timmermann, Gudrun Fleischhack
INTRODUCTION: Radiotherapy with craniospinal irradiation (CSI) is an important part of initial treatment for medulloblastoma in most children. Radiotherapy after recurrence is currently not widely used. This analysis aims to evaluate whether re-irrad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45a8abb363b19ee42c983a985f9d1248
Autor:
Ruth Mikasch, Till Milde, Rolf-Dieter Kortmann, Olaf Witt, Martin Mynarek, Kristian W. Pajtler, Gudrun Fleischhack, Stefan Dietzsch, Brigitte Bison, Christine Gaab, Stephan Tippelt, Stefan Rutkowski, Ulrich Schüller, Monika Warmuth-Metz, Jonas E. Adolph, Beate Timmermann, Torsten Pietsch, Stefan M. Pfister
Publikováno v:
Journal of Neuro-Oncology
Purpose Survival in recurrent ependymoma (EPN) depends mainly on the extent of resection achieved. When complete resection is not feasible, chemotherapy is often used to extend progression-free and overall survival. However, no consistent effect of c
Autor:
Jonas E. Adolph, Denise Obrecht, Martin Mynarek, Julia Zeller, Katja von Hoff, Andreas Faldum, Monika Warmuth-Metz, Beate Timmermann, Stephan Tippelt, Torsten Pietsch, Robert Kwiecien, Michael C. Frühwald, Stefan M. Pfister, Udo Bode, Jürgen Kraus, Stefan Rutkowski, Ruth Mikasch, Rolf-Dieter Kortmann, Ulrich Schüller, Olaf Witt, Gudrun Fleischhack, Kristian W. Pajtler, Hendrik Witt, Brigitte Bison
Background Survival in recurrent ependymomas in children and adolescents mainly depends on the extent of resection. Studies on repeated radiotherapy and chemotherapy at relapse have shown conflicting results. Methods Using data from the German multi-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d8b93970bb7e0827e222094eed4ef9f
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/83272
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/83272
Autor:
Torsten Pietsch, Jonas E. Adolph, Hendrik Witt, Rolf-Dieter Kortmann, Stephan Tippelt, Olaf Witt, Stefan Dietzsch, Ruth Mikasch, Monika Warmuth-Metz, Brigitte Bison, Gudrun Fleischhack, Beate Timmermann, Stefan M. Pfister, Kristian W. Pajtler
Publikováno v:
Neuro-Oncology
INTRODUCTION The efficacy of chemotherapy in recurrent ependymoma is unclear. We present results from the German HIT-REZ-studies. METHODS 137 patients were analyzed regarding the treatment with chemotherapy at first recurrence, the time from first re